A giant in both humanity and science, Jaume was an extraordinary mentor and role model to countless physicians and researchers in the liver community. He brought people together across borders — of country, discipline, and perspective — always with humility, grace, and brilliance.
His impact knew no borders — and neither does the gratitude we feel for having known him.
Giada Sebastiani, CASL President-Elect
The global hepatology community mourns the passing of Professor Jaume Bosch, a pioneering clinician-scientist, educator, and leader whose work transformed the field of liver disease research and care. Born in Girona, Catalonia, in 1947, Professor Bosch dedicated over five decades to advancing the understanding and treatment of portal hypertension and liver disease.
A graduate of the University of Barcelona Medical School, he trained at Yale University under Professor Roberto Groszmann, a collaboration that shaped his lifelong research into hepatic hemodynamics. Upon returning to Barcelona, he established one of the world’s most influential laboratories in portal hypertension, mentoring generations of hepatologists and authoring over 400 peer-reviewed publications.
Professor Bosch’s legacy includes groundbreaking work in the management of variceal bleeding, non-invasive portal pressure measurement, and the use of statins in liver disease. His contributions have directly improved the lives of countless patients worldwide.
In recognition of his extraordinary impact, in 2012 Professor Bosch was awarded the CASL Gold Medal Award by the Canadian Association for the Study of the Liver, honoring his outstanding contributions to liver research and international collaboration to the Canadian liver community.
Beyond his scientific achievements, Professor Bosch was known for his humility, generosity, and dedication to mentorship. He leaves behind a legacy of excellence, compassion, and enduring influence in hepatology.
English 
French